source
- AstraZeneca highlights broad oncology portfolio at ESMO conferenceAt the European Society for Medical Oncology (ESMO) meeting in Madrid, AstraZeneca used the platform to showcase its cancer research. The company presented data on both established medicines and n…
- Amgen and AstraZeneca present new combo data for extensive-stage small cell lung cancer at ESMODay two of the European Society for Medical Oncology meeting in Madrid saw nearly 40,000 attendees gathering for the latest cancer research updates, as reported in the STAT+ newsletter. The sessio…